What AI says about Rejoyn
Rejoyn is a company with a website at rejoyn.com. The available site content here is limited, preventing a precise description of its products or services. Based on the URL alone, the exact focus of Rejoyn cannot be determined from this page.
Since Jul 5Updated Nov 14, 2026Based on 280 AI answers
Reviewed by Dimitry Apollonsky
6%
of AI answers about Rejoyn and its rivals · since Jul 5
Based on 280 AI answers
- ChatGPT3%
- Google AI Mode9%
How often AI mentions Rejoyn
of AI answers about Rejoyn and its rivals
- · ChatGPT switched to GPT-6 Luna
Questions and answers
- Most mentionedMentioned in
- Which digital therapeutics companies have achieved reimbursement codes from payers?on this questionPear Therapeutics shares the lead for mentions with 1 more43%
Excerpts where Rejoyn appeared in the AI's answer
Google AI ModeSep 14, 2026, Google AI Mode Click Therapeutics – Developer of prescription digital therapeutics like Rejoyn (cleared for major depressive disorder)
Google AI ModeAug 29, 2026, Google AI Mode Their product Rejoyn™ (the first FDA-cleared prescription digital therapeutic for major depressive disorder as an adjunct to antidepressants) qualifies under the CMS digital mental health treatment HCPCS billing framework.
Rejoyn in AI answers
Which digital therapeutics companies have achieved reimbursement codes from payers?
Sites AI cites
The page AI cites most often when it mentions Rejoyn
Check it mentions Rejoyn and gets the details right.
Brands AI mentions
Mentioned in
- Somryst19%
- Click Therapeutics19%
- SleepioRx15%
- Pear Therapeutics13%
- reSET-O11%
